Most people who develop a fever after a tick bite assume Lyme disease until proven otherwise — but two emerging viruses with no approved treatments and no widely available diagnostic tests are quietly expanding their geographic footprint into densely populated areas of the northeastern United States, where tens of millions of people recreate outdoors each summer.
A five-year cohort study enrolling 107 adults in Suffolk County, New York — one of the most tick-exposed suburban populations in the country — screened febrile patients for three neurologically dangerous tick-borne viruses: Powassan, Heartland, and Bourbon. Using plaque-reduction neutralization testing, the gold standard for detecting virus-specific antibodies, investigators identified serologic evidence of Heartland virus in one patient and Bourbon virus in two. Critically, fourfold rises in neutralizing antibody titers in one Heartland and one Bourbon case confirmed acute or recent infection rather than historical exposure. No Powassan cases were detected in this cohort.
The clinical weight of these findings extends well beyond three individuals. Heartland virus, first characterized in Missouri in 2009, is transmitted by the lone star tick and has been associated with severe thrombocytopenia, leukopenia, and fatigue — a clinical picture easily mistaken for ehrlichiosis. Bourbon virus, identified in Kansas in 2014, carries a grimmer profile; early case series recorded fatalities in immunocompromised patients, and its reservoir host remains incompletely understood. Both pathogens are phlebovirus-family members for which no antiviral therapies are approved. Suffolk County's tick population has historically been dominated by Ixodes scapularis, the deer tick, but lone star tick range expansion northward along the Atlantic seaboard has been well-documented over the past two decades, providing a plausible transmission vector. This study is limited by its small convenience sample and the absence of entomologic data confirming local tick species. Nonetheless, its geographic confirmation should prompt emergency physicians in the Northeast to broaden differential diagnoses for post-tick febrile illness beyond Lyme and to advocate urgently for point-of-care assay development.